Option Care Health (OPCH) Expected to Announce Quarterly Earnings on Wednesday

Option Care Health (NASDAQ:OPCH) is projected to post its quarterly earnings results before the market opens on Wednesday, February 26th. Analysts expect Option Care Health to post earnings of $0.33 per share and revenue of $1.29 billion for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $32.08 on Tuesday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market cap of $5.46 billion, a P/E ratio of 26.96, a P/E/G ratio of 2.30 and a beta of 1.35. The firm’s fifty day moving average is $27.89 and its two-hundred day moving average is $27.98. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.17.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. UBS Group assumed coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Barrington Research lifted their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 14th. Finally, Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.